{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:13:58Z","timestamp":1788304438646,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":40,"publisher":"Springer US","isbn-type":[{"value":"9781071652831","type":"print"},{"value":"9781071652848","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5284-8_1","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:20:35Z","timestamp":1788301235000},"page":"1-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Clinically Relevant Genes Using Machine Learning Techniques"],"prefix":"10.1007","author":[{"given":"Ken","family":"Asada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3","key":"1_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working G","year":"2001","unstructured":"Biomarkers Definitions Working G (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89\u201395. https:\/\/doi.org\/10.1067\/mcp.2001.113989","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu K, Tavel JA (2010) What are biomarkers?. Curr Opin HIV AIDS 5(6):463\u2013466. https:\/\/doi.org\/10.1097\/COH.0b013e32833ed177","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"1_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1470-2045(01)00560-5","volume":"2","author":"PR Srinivas","year":"2001","unstructured":"Srinivas PR, Kramer BS, Srivastava S (2001) Trends in biomarker research for cancer detection. Lancet Oncol 2(11):698\u2013704. https:\/\/doi.org\/10.1016\/S1470-2045(01)00560-5","journal-title":"Lancet Oncol"},{"issue":"7","key":"1_CR4","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","volume":"187","author":"A Passaro","year":"2024","unstructured":"Passaro A et al (2024) Cancer biomarkers: emerging trends and clinical implications for personalized treatment. Cell 187(7):1617\u20131635. https:\/\/doi.org\/10.1016\/j.cell.2024.02.041","journal-title":"Cell"},{"issue":"3","key":"1_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3978\/j.issn.2218-676X.2015.06.04","volume":"4","author":"N Goossens","year":"2015","unstructured":"Goossens N, Nakagawa S, Sun X, Hoshida Y (2015) Cancer biomarker discovery and validation. Transl Cancer Res 4(3):256\u2013269. https:\/\/doi.org\/10.3978\/j.issn.2218-676X.2015.06.04","journal-title":"Transl Cancer Res"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"666937","DOI":"10.3389\/fonc.2021.666937","volume":"11","author":"K Asada","year":"2021","unstructured":"Asada K et al (2021) Integrated analysis of whole genome and epigenome data using machine learning technology: toward the establishment of precision oncology. Front Oncol 11:666937. https:\/\/doi.org\/10.3389\/fonc.2021.666937","journal-title":"Front Oncol"},{"issue":"5281","key":"1_CR7","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","volume":"273","author":"N Risch","year":"1996","unstructured":"Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273(5281):1516\u20131517. https:\/\/doi.org\/10.1126\/science.273.5281.1516","journal-title":"Science"},{"issue":"5343","key":"1_CR8","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1126\/science.278.5343.1580","volume":"278","author":"FS Collins","year":"1997","unstructured":"Collins FS, Guyer MS, Charkravarti A (1997) Variations on a theme: cataloging human DNA sequence variation. Science 278(5343):1580\u20131581. https:\/\/doi.org\/10.1126\/science.278.5343.1580","journal-title":"Science"},{"issue":"5287","key":"1_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1126\/science.274.5287.536","volume":"274","author":"ES Lander","year":"1996","unstructured":"Lander ES (1996) The new genomics: global views of biology. Science 274(5287):536\u2013539. https:\/\/doi.org\/10.1126\/science.274.5287.536","journal-title":"Science"},{"issue":"3","key":"1_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen B et al (2022) Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell 185(3):563\u2013575.e511. https:\/\/doi.org\/10.1016\/j.cell.2022.01.003","journal-title":"Cell"},{"issue":"7","key":"1_CR11","doi-asserted-by":"publisher","first-page":"e2323336","DOI":"10.1001\/jamanetworkopen.2023.23336","volume":"6","author":"J Matsubara","year":"2023","unstructured":"Matsubara J et al (2023) First-line genomic profiling in previously untreated advanced solid tumors for identification of targeted therapy opportunities. JAMA Netw Open 6(7):e2323336. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.23336","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19949-6","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin Y et al (2020) Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction. Nat Commun 11(1):6091. https:\/\/doi.org\/10.1038\/s41467-020-19949-6","journal-title":"Nat Commun"},{"issue":"12","key":"1_CR13","doi-asserted-by":"publisher","first-page":"e2347700","DOI":"10.1001\/jamanetworkopen.2023.47700","volume":"6","author":"T Sakamoto","year":"2023","unstructured":"Sakamoto T et al (2023) Biomarker testing in patients with unresectable advanced or recurrent non-small cell lung cancer. JAMA Netw Open 6(12):e2347700. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.47700","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02035-6","volume":"23","author":"S Kaneko","year":"2024","unstructured":"Kaneko S et al (2024) Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations. Mol Cancer 23(1):126. https:\/\/doi.org\/10.1186\/s12943-024-02035-6","journal-title":"Mol Cancer"},{"issue":"8","key":"1_CR15","doi-asserted-by":"publisher","first-page":"e1002197","DOI":"10.1371\/journal.pgen.1002197","volume":"7","author":"RS Fehrmann","year":"2011","unstructured":"Fehrmann RS et al (2011) Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 7(8):e1002197. https:\/\/doi.org\/10.1371\/journal.pgen.1002197","journal-title":"PLoS Genet"},{"issue":"1","key":"1_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","volume":"8","author":"S Qiu","year":"2023","unstructured":"Qiu S et al (2023) Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal Transduct Target Ther 8(1):132. https:\/\/doi.org\/10.1038\/s41392-023-01399-3","journal-title":"Signal Transduct Target Ther"},{"issue":"8006","key":"1_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","volume":"628","author":"MK Karjalainen","year":"2024","unstructured":"Karjalainen MK et al (2024) Genome-wide characterization of circulating metabolic biomarkers. Nature 628(8006):130\u2013138. https:\/\/doi.org\/10.1038\/s41586-024-07148-y","journal-title":"Nature"},{"issue":"11","key":"1_CR18","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1373\/clinchem.2011.163188","volume":"57","author":"S Jaisson","year":"2011","unstructured":"Jaisson S, Pietrement C, Gillery P (2011) Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Clin Chem 57(11):1499\u20131505. https:\/\/doi.org\/10.1373\/clinchem.2011.163188","journal-title":"Clin Chem"},{"issue":"3","key":"1_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1073\/pnas.0610204104","volume":"104","author":"CR Scherzer","year":"2007","unstructured":"Scherzer CR et al (2007) Molecular markers of early Parkinson\u2019s disease based on gene expression in blood. Proc Natl Acad Sci U S A 104(3):955\u2013960. https:\/\/doi.org\/10.1073\/pnas.0610204104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2021.100050","volume":"1","author":"K Su","year":"2021","unstructured":"Su K, et al (2021) Pan-cancer analysis of pathway-based gene expression pattern at the individual level reveals biomarkers of clinical prognosis. Cell Rep Methods 1(4), 100050. https:\/\/doi.org\/10.1016\/j.crmeth.2021.100050","journal-title":"Cell Rep Methods"},{"issue":"6","key":"1_CR21","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.cell.2019.08.018","volume":"178","author":"D Demircioglu","year":"2019","unstructured":"Demircioglu D et al (2019) A pan-cancer transcriptome analysis reveals pervasive regulation through alternative promoters. Cell 178(6):1465\u20131477.e1417. https:\/\/doi.org\/10.1016\/j.cell.2019.08.018","journal-title":"Cell"},{"issue":"10","key":"1_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-024-00932-9","volume":"21","author":"J Budczies","year":"2024","unstructured":"Budczies J et al (2024) Tumour mutational burden: clinical utility, challenges and emerging improvements. Nat Rev Clin Oncol 21(10):725\u2013742. https:\/\/doi.org\/10.1038\/s41571-024-00932-9","journal-title":"Nat Rev Clin Oncol"},{"issue":"25","key":"1_CR23","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ van de Vijver","year":"2002","unstructured":"van de Vijver MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999\u20132009. https:\/\/doi.org\/10.1056\/NEJMoa021967","journal-title":"N Engl J Med"},{"issue":"1","key":"1_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi X et al (2024) Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduct Target Ther 9(1):192. https:\/\/doi.org\/10.1038\/s41392-024-01885-2","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1_CR25","doi-asserted-by":"publisher","first-page":"100932","DOI":"10.1016\/j.xcrm.2023.100932","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen F, Creighton CJ (2023) Pan-cancer molecular subtypes of metastasis reveal distinct and evolving transcriptional programs. Cell Rep Med 4(2):100932. https:\/\/doi.org\/10.1016\/j.xcrm.2023.100932","journal-title":"Cell Rep Med"},{"issue":"1","key":"1_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33291-z","volume":"13","author":"S Chawla","year":"2022","unstructured":"Chawla S et al (2022) Gene expression based inference of cancer drug sensitivity. Nat Commun 13(1):5680. https:\/\/doi.org\/10.1038\/s41467-022-33291-z","journal-title":"Nat Commun"},{"issue":"1","key":"1_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21997-5","volume":"12","author":"P Jia","year":"2021","unstructured":"Jia P et al (2021) Deep generative neural network for accurate drug response imputation. Nat Commun 12(1):1740. https:\/\/doi.org\/10.1038\/s41467-021-21997-5","journal-title":"Nat Commun"},{"issue":"7187","key":"1_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature06913","volume":"452","author":"CL Sawyers","year":"2008","unstructured":"Sawyers CL (2008) The cancer biomarker problem. Nature 452(7187):548\u2013552. https:\/\/doi.org\/10.1038\/nature06913","journal-title":"Nature"},{"issue":"6127","key":"1_CR29","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B et al (2013) Cancer genome landscapes. Science 339(6127):1546\u20131558. https:\/\/doi.org\/10.1126\/science.1235122","journal-title":"Science"},{"issue":"4","key":"1_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biom10040524","volume":"10","author":"K Asada","year":"2020","unstructured":"Asada K, et al (2020) Uncovering prognosis-related genes and pathways by multi-omics analysis in lung cancer. Biomolecules 10(4):524. https:\/\/doi.org\/10.3390\/biom10040524","journal-title":"Biomolecules"},{"issue":"10","key":"1_CR31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/biom10101460","volume":"10","author":"S Takahashi","year":"2020","unstructured":"Takahashi S, et al (2020) Predicting deep learning based multi-omics parallel integration survival subtypes in lung cancer using reverse phase protein array data. Biomolecules 10(10):1460. https:\/\/doi.org\/10.3390\/biom10101460","journal-title":"Biomolecules"},{"issue":"9","key":"1_CR32","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/bioinformatics\/btx812","volume":"34","author":"L Wei","year":"2018","unstructured":"Wei L et al (2018) TCGA-assembler 2: software pipeline for retrieval and processing of TCGA\/CPTAC data. Bioinformatics 34(9):1615\u20131617. https:\/\/doi.org\/10.1093\/bioinformatics\/btx812","journal-title":"Bioinformatics"},{"issue":"6","key":"1_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nmeth.2956","volume":"11","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Qiu P, Ji Y (2014) TCGA-assembler: open-source software for retrieving and processing TCGA data. Nat Methods 11(6):599\u2013600. https:\/\/doi.org\/10.1038\/nmeth.2956","journal-title":"Nat Methods"},{"issue":"12","key":"1_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"issue":"1","key":"1_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616","journal-title":"Bioinformatics"},{"issue":"9","key":"1_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad547","volume":"39","author":"B Muzellec","year":"2023","unstructured":"Muzellec B, Telenczuk M, Cabeli V, Andreux M (2023) PyDESeq2: a Python package for bulk RNA-seq differential expression analysis. Bioinformatics 39(9), btad547. https:\/\/doi.org\/10.1093\/bioinformatics\/btad547","journal-title":"Bioinformatics"},{"issue":"1","key":"1_CR37","doi-asserted-by":"publisher","first-page":"102926","DOI":"10.1016\/j.xpro.2024.102926","volume":"5","author":"LAE Nagai","year":"2024","unstructured":"Nagai LAE, Lee S, Nakato R (2024) Protocol for identifying differentially expressed genes using the RumBall RNA-seq analysis platform. STAR Protoc 5(1):102926. https:\/\/doi.org\/10.1016\/j.xpro.2024.102926","journal-title":"STAR Protoc"},{"issue":"12","key":"1_CR38","doi-asserted-by":"publisher","first-page":"e0190152","DOI":"10.1371\/journal.pone.0190152","volume":"12","author":"J Costa-Silva","year":"2017","unstructured":"Costa-Silva J, Domingues D, Lopes FM (2017) RNA-Seq differential expression analysis: an extended review and a software tool. PLoS One 12(12):e0190152. https:\/\/doi.org\/10.1371\/journal.pone.0190152","journal-title":"PLoS One"},{"issue":"2","key":"1_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand J et al (2019) Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc 14(2):482\u2013517. https:\/\/doi.org\/10.1038\/s41596-018-0103-9","journal-title":"Nat Protoc"},{"issue":"1","key":"1_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02093-w","volume":"23","author":"K Asada","year":"2024","unstructured":"Asada K et al (2024) Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets. Mol Cancer 23(1):182. https:\/\/doi.org\/10.1186\/s12943-024-02093-w","journal-title":"Mol Cancer"}],"container-title":["Methods in Molecular Biology","AI\/ML-Driven Gene Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5284-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:20:37Z","timestamp":1788301237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5284-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652831","9781071652848"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5284-8_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}